INS and cancer: Insulin therapy has been the therapy of choice in people with complex medical conditions beyond their diabetes, from renal failure to cirrhosis to cancer therapy and many others, such that its use is always associated with poorer life expectancy in comparative pharmaco‐epidemiological observational studies.